Veracyte Inc (VCYT) Reports Q3 2022 Financial Results
Veracyte Inc (VCYT) announced its financial results for the period ending Q3 2022.
Key Financial Highlights:
Revenue: 109784
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 154196
Increased second quarter total revenue by 32% to $
9 million, compared to the second quarter of 2021;
Grew total test volume to 24,904, an increase of 19% compared to the second quarter of 2021;
📋 VERACYTE, INC. (VCYT) - Financial Results
Filing Date: 2022-08-02
Accepted: 2022-08-02 16:15:39
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: